Actinium Pharmaceuticals, Inc. (ATNM) stock
ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/3079% below fair value
$1.64+0.05 (+3.14%)
Close on Nov 13, 2026Market cap $51.56MP/E 4.6Yield –
Actinium Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Actinium Pharmaceuticals's operating margin for the twelve months ending Dec 31, 2025 was -40274.4%. For fiscal 2025 it was -40274.4%, against -64098.8% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -40274.4% | +23824.3 |
| FY2023 | Dec 31, 2023 | -64098.8% | −60787.7 |
| FY2022 | Dec 31, 2022 | -3311.1% | −1128.9 |
| FY2021 | Dec 31, 2021 | -2182.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 78.8% | +628.1 |
| Q3 FY2025 | Sep 30, 2025 | -6324.4% | +28666.9 |
| Q3 FY2022 | Sep 30, 2022 | -21775.6% | −18999.2 |
| Q2 FY2022 | Jun 30, 2022 | -17444.4% | −15536.5 |
| Q1 FY2022 | Mar 31, 2022 | -549.4% | +314.3 |
| Q4 FY2021 | Dec 31, 2021 | -34991.3% | – |
| Q3 FY2021 | Sep 30, 2021 | -2776.4% | – |
| Q2 FY2021 | Jun 30, 2021 | -1907.9% | – |
| Q1 FY2021 | Mar 31, 2021 | -863.7% | – |
See a number that looks wrong?